Products - Cyprus Market

Disclaimer: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.

Download PDF
Product Name Strength and Dosage form Brand/Innovator Indication Dossier Availability
APIXABAN 2.5mg, 5mg Film-coated tablets Eliquis® (Pfizer) Antithrombotic agents YES
EDOXABAN TOSYLATE 15mg, 30mg, 60mg Film-coated tablets Lixiana® (Daiichi Sankyo) Antithrombotic agents Q3-2025
RIVAROXABAN 2.5mg, 10mg, 15mg, 20mg Film-coated tablets Xarelto® (Bayer) Antithrombotic agents YES
TICAGRELOR 60mg, 90mg Film-coated tablets Brilique® (AstraZeneca) Antithrombotic agents YES
ACETYLSALICYLIC ACID 75mg Gastro-resistant tablets Nu-Seals® (Phadisco) Antithrombotic agents Q1-2026
LETERMOVIR 240mg, 480mg Film-coated tablets Prevymis® (Merck Sharp & Dohme) Antivirals (Cytomegalovirus (CMV)) Q3-2026
ENTECAVIR 0.5mg, 1mg Film-coated tablets Baraclude® (Bristol-Myers) Antivirals (Hepatitis B virus (HBV)) YES
TENOFOVIR DISOPROXIL 123mg, 163mg, 204mg, 245mg Film-coated tablets Viread® (Gilead) Antivirals (HIV and/or HBV) YES
ABACAVIR / LAMIVUDINE 600mg/300mg Film-coated tablets Kivexa® (ViiV Healthcare) Antivirals (HIV) YES
ATAZANAVIR 100mg, 150mg, 200mg, 300mg Capsules, hard Reyataz® (Bristol-Myers) Antivirals (HIV) YES

* Available for distribution only.